HIV prevention drug hailed as breakthrough, but who gets access?
Lenacapavir, a twice-a-year injection could transform HIV prevention, but it will not be available to all., A medicine injected just twice a year could transform the fight against HIV. In a 2024 clinical trial involving more than 2,000 young women in South Africa and Uganda, no participants who received lenacapavirContinue Reading












